title: Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
abstract: OBJECTIVE
  To assess the margins required for excision of lentigo maligna (LM) and lentigo maligna melanoma (LMM) by the technique of mapped serial excision (MSE), and to assess the efficacy of MSE.
  
  
  METHODS
  An interventional, prospective, noncontrolled case series.
  
  
  METHODS
  Tertiary referral, dermatologic surgery unit.
  
  
  METHODS
  Consecutive patients with head and neck LM or LMM who underwent MSE between March 1, 1993, and October 31, 2002.
  
  
  METHODS
  The MSE of LM or LMM.
  
  
  METHODS
  The number of 5-mm levels for excision of LM and LMM and recurrence.
  
  
  RESULTS
  One hundred sixty-one LMs or LMMs in 155 patients were treated. Thirty percent (37 of 125) of LMs required more than 5-mm margins. For LMMs less than 1 mm in Breslow thickness, 12% (4/32) required more than 10-mm margins. For primary tumors, 20% of LMs (18 of 91) required more than 5-mm margins, while 10% of LMMs less than 1 mm in Breslow thickness (2 of 21) required more than a 10-mm margin. For recurrent tumors, 56% of LMs (19/34) required more than a 5-mm margin. Mean follow-up of 38 months (range, 5-100 months) showed 4 recurrences (2%) after MSE. The extrapolated recurrence at 5 years was 5.0%.
  
  
  CONCLUSIONS
  The current recommendations of 5-mm margins for LM and 10-mm margins for LMM less than 1 mm in Breslow thickness are often insufficient. Our results demonstrate the importance of margin-controlled excision, particularly in recurrent lesions. The use of MSE offers a high cure rate, in conjunction with tissue conservation.
authors.affiliation: Department of Dermatology and Oculoplastic and Orbital Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia.
authors.forename: Shyamala C
authors.initials: SC
authors.lastname: Huilgol
authors.forename: Dinesh
authors.initials: D
authors.lastname: Selva
authors.forename: Celia
authors.initials: C
authors.lastname: Chen
authors.forename: Dudley C
authors.initials: DC
authors.lastname: Hill
authors.forename: Craig L
authors.initials: CL
authors.lastname: James
authors.forename: Amanda
authors.initials: A
authors.lastname: Gramp
authors.forename: Raman
authors.initials: R
authors.lastname: Malhotra
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D016001:Confidence Intervals; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000473:pathology / Q000601:surgery*; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D015580:Mohs Surgery / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000473:pathology*; D009367:Neoplasm Staging; D011336:Probability; D011446:Prospective Studies; D012086:Reoperation / Q000706:statistics & numerical data; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000473:pathology / Q000601:surgery*; D018709:Statistics, Nonparametric; D016896:Treatment Outcome